Vir Biotechnology, Inc.

VIRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$68.6M

▼ 7.6% YoY

Net Income

-$438.0M

▲ 16.1% YoY

EPS

$-3.16

▲ 17.5% YoY

Cash

$232.2M

▲ 4.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.